Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 26, 2024Frontiers in MedicineOpen Access

The use of extended-release tacrolimus twice a day might be beneficial for selected kidney transplant recipients: a case report

View Full Paper
Ask AI
Bookmark
Share

Authors

LFLouise FüeßlLKLena KreuzerKNKajetan Nierychlewski

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Füeßl et al. (2024) studied this question.

synapsesocial.com/papers/68e63296b6db6435875c4cc0https://doi.org/10.3389/fmed.2024.1336035
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Effectiveness of Empirical Tacrolimus Dosing in Renal Graft Immunosuppression2026
  2. 2New-Onset Diabetes After Transplantation in Renal Recipients: A Pilot Comparative Study of Immediate vs. Extended-Release Tacrolimus Formulation2025 · 1 citations
  3. 3Extended-Release Tacrolimus Versus LifeCycle Pharma Tacrolimus in Kidney Transplant Recipients: A Switch Study2026
  4. 4Immediate-Release vs. Extended-Release Tacrolimus: Comparing Blood Pressure Control in Kidney Transplant Recipients – A Retrospective Cohort Study2024
  5. 5Evaluation of Tacrolimus Concentrations and Clinical Outcomes Between Extended and Immediate Release Formulations in Kidney Transplant2024 · 1 citations